High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences
- PMID: 1465454
- PMCID: PMC50716
- DOI: 10.1073/pnas.89.24.12150
High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences
Abstract
A line of transgenic mice (alpha H beta S-11; where alpha H is human alpha-globin) was created in which the human beta S and human alpha 2 globin genes, each linked to the beta-globin locus control region, were cointegrated into the mouse genome. On a normal genetic background, the transgenic mice produced 36% human beta S-globin chains with an alpha H/beta S ratio of 1.3. Higher levels of beta S were achieved by breeding the transgenic mice with mutant mice carrying a mouse beta major-globin gene deletion. Mice heterozygous for the beta major deletion (alpha H beta S[beta MD]; MD, mouse deletion) had 54% beta S with an alpha H/beta S ratio of 1.0; mice homozygous for the beta major deletion (alpha H beta S[beta MDD]) had 72.5% beta S and an alpha H/beta S ratio of 0.73. Because mouse alpha chains inhibit hemoglobin (Hb) S polymerization, we bred the mice to heterozygosity for a mouse alpha-globin deletion. These mice (alpha H beta S[alpha MD beta MDD]) had an increased alpha H/beta S ratio of 0.89 but expressed 65% beta S. Expression of the human genes cured the thalassemic phenotype associated with the murine beta major deletion. Transgenic alpha H beta S[beta MDD] mice had normal hematocrit and Hb and somewhat elevated reticulocytes (6% vs. 3% for control), whereas the mice carrying the alpha-globin deletion (alpha H beta S[alpha MD beta MDD]) had a normal hematocrit and Hb and more elevated reticulocytes (10.3 +/- 7.6% vs. 3.4 +/- 1.0%). Expression of the transgene restored a normal distribution of erythrocyte densities when compared to thalassemic mice; however, the average mean corpuscular Hb concentration of alpha H beta S[beta MDD] mice increased to 35.7 g/dl (vs. control 33.7 g/dl) whereas that of alpha H beta S[alpha MD beta MDD] mice was further elevated to 36.3 g/dl. The intrinsic oxygen affinity was increased in transgenic mouse erythrocytes at 280 milliosmolal, and the PO2 at midsaturation of alpha H beta S[alpha MD beta MDD] erythrocytes was higher than that of alpha H beta S[beta MDD] cells (37.4 +/- 2 vs. 33.5 +/- 1 mmHg). The higher values of the mean corpuscular Hb concentration and intrinsic PO2 at midsaturation, which favor in vivo sickling, may explain the slightly more severe hematological picture in alpha H beta S[alpha MD beta MDD] mice. We conclude that the transgenic mouse with high Hb S expression does not exhibit adult anemia but does have abnormal hematological features: increased erythrocyte density, high oxygen affinity, and reticulocytosis with increased stress reticulocytes.
Similar articles
-
High expression of human beta S- and alpha-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia.Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12155-9. doi: 10.1073/pnas.89.24.12155. Proc Natl Acad Sci U S A. 1992. PMID: 1465455 Free PMC article.
-
A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbS-Antilles results in increased phenotypic severity.Blood. 1995 Sep 15;86(6):2419-28. Blood. 1995. PMID: 7662990
-
Towards a transgenic mouse model of sickle cell disease: hemoglobin SAD.EMBO J. 1991 Nov;10(11):3157-65. doi: 10.1002/j.1460-2075.1991.tb04877.x. EMBO J. 1991. PMID: 1915288 Free PMC article.
-
"Sickling" in vertebrates: Animal studies vs. sickle cell disease.Blood Rev. 2019 Jul;36:88-94. doi: 10.1016/j.blre.2019.05.001. Epub 2019 May 8. Blood Rev. 2019. PMID: 31084943 Review.
-
Fate of alpha-hemoglobin chains and erythrocyte defects in beta-thalassemia.Ann N Y Acad Sci. 1990;612:106-17. doi: 10.1111/j.1749-6632.1990.tb24296.x. Ann N Y Acad Sci. 1990. PMID: 2291540 Review.
Cited by
-
NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines.Blood. 2009 Jul 16;114(3):667-76. doi: 10.1182/blood-2009-02-205492. Epub 2009 May 11. Blood. 2009. PMID: 19433855 Free PMC article.
-
Molecular mechanisms of hepatic dysfunction in sickle cell disease: lessons from Townes mouse model.Am J Physiol Cell Physiol. 2022 Aug 1;323(2):C494-C504. doi: 10.1152/ajpcell.00175.2022. Epub 2022 Jun 27. Am J Physiol Cell Physiol. 2022. PMID: 35759437 Free PMC article. Review.
-
Understanding erythroid physiology and pathology in humanized mice: A closer look.Br J Haematol. 2025 May;206(5):1272-1284. doi: 10.1111/bjh.20023. Epub 2025 Feb 25. Br J Haematol. 2025. PMID: 40007143 Free PMC article. Review.
-
Early and prominent alterations in hemodynamics, signaling, and gene expression following renal ischemia in sickle cell disease.Am J Physiol Renal Physiol. 2010 Apr;298(4):F892-9. doi: 10.1152/ajprenal.00631.2009. Epub 2010 Jan 27. Am J Physiol Renal Physiol. 2010. PMID: 20107113 Free PMC article.
-
Abnormal Regulation of Microvascular Tone in a Murine Model of Sickle Cell Disease Assessed by Contrast Ultrasound.J Am Soc Echocardiogr. 2015 Sep;28(9):1122-8. doi: 10.1016/j.echo.2015.05.012. Epub 2015 Jun 27. J Am Soc Echocardiogr. 2015. PMID: 26123012 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials